Home › Funds › BIOS Capital Management, LP › RNTX
BIOS Capital Management, LP position in RNTX
REIN THERAPEUTICS INC · Health Care
BIOS Capital Management, LP reported holding 2,982,375 shares of RNTX (REIN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.40B, representing 7.02% of its reported portfolio and ranking #4 among its reported holdings. BIOS Capital Management, LP has disclosed RNTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How BIOS Capital Management, LP's RNTX position evolved
BIOS Capital Management, LP first disclosed a stake in RNTX in Q4 2024 at 1,690,751 shares (US$3.9M). The position peaked in Q3 2026 at 2,982,375 shares, worth US$2.40B. Across 8 filings, BIOS Capital Management, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,982,375 shares valued at US$2.40B. Notable position changes include a 50% increase in Q2 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.69M | $3.89M | New |
| Q1 2025 | 1.69M | $2.99M | Hold |
| Q2 2025 | 1.69M | $2.37M | Hold |
| Q3 2025 | 1.69M | $1.94M | Hold |
| Q4 2025 | 1.69M | $1.96M | Hold |
| Q1 2026 | 1.98M | $2.58M | Add |
| Q2 2026 | 2.98M | $3.10M | Add |
| Q3 2026 | 2.98M | $2.40B | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RNTX and 13F data
RNTX (REIN THERAPEUTICS INC) is a Health Care company. 49 other funds we track also report a position in RNTX — the largest reported positions include Voss Capital, LP (US$5.5M), Cable Car Capital, LP (US$5.4M), GREAT POINT PARTNERS LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RNTX
- Voss Capital, LP 5.26M sh · $5.47M · Q2 2026
- Cable Car Capital, LP 5.20M sh · $5.40M · Q2 2026
- GREAT POINT PARTNERS LLC 2.58M sh · $2.68M · Q2 2026
- Velan Capital Investment Management LP 1.70M sh · $1.77M · Q2 2026
- Prosight Management, LP 1.66M sh · $1.33M · Q3 2026
- Empery Asset Management, LP 370.83K sh · $385.67K · Q2 2026
More on BIOS Capital Management, LP
FAQ
How long has BIOS Capital Management, LP held RNTX?
BIOS Capital Management, LP has disclosed RNTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is BIOS Capital Management, LP's current position in RNTX?
As of Q3 2026, BIOS Capital Management, LP holds 2.98M shares of RNTX (REIN THERAPEUTICS INC), valued at $2.40B, representing 7.02% of its reported portfolio and ranking #4.
Has BIOS Capital Management, LP been buying or selling RNTX?
In the latest 13F filing (Q3 2026), BIOS Capital Management, LP held unchanged its position in RNTX. The position peaked in Q3 2026 at 2.98M shares.
Which other funds hold RNTX?
Other major institutional holders of RNTX include Voss Capital, LP, Cable Car Capital, LP, GREAT POINT PARTNERS LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.